First Citizens Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,198
Closed -$268K 113
2023
Q2
$268K Buy
+4,198
New +$282K 0.18% 93
2022
Q4
$302K Hold
4,198
0.26% 71
2022
Q3
$298K Hold
4,198
0.29% 68
2022
Q2
$323K Buy
4,198
+128
+3% +$9.75K 0.28% 65
2022
Q1
$297K Hold
4,070
0.22% 80
2021
Q4
$254K Hold
4,070
0.19% 90
2021
Q3
$241K Sell
4,070
-125
-3% -$8.23K 0.19% 91
2021
Q2
$280K Hold
4,195
0.21% 91
2021
Q1
$265K Sell
4,195
-2,136
-34% -$133K 0.22% 86
2020
Q4
$393K Buy
+6,331
New +$389K 0.34% 61

Other funds holding BMY

First Citizens Financial Corp's BMY Position: Q3 2023 in Review

First Citizens Financial Corp sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,198 shares — an estimated $268K sold.

First Citizens Financial Corp first reported a position in BMY in Q4 2020 and held it in 10 quarters. The position peaked at $393K in Q4 2020. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • First Citizens Financial Corp reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • First Citizens Financial Corp sold 4,198 Bristol-Myers Squibb shares in Q3 2023, an estimated $268K.
  • First Citizens Financial Corp first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 10 quarters.
  • First Citizens Financial Corp's Bristol-Myers Squibb position peaked at $393K in Q4 2020.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on First Citizens Financial Corp's 13F filing for Q3 2023, filed 13 Oct 2023.